OpenAlex
PricingAboutJobs
Log inGet started
Work

A Dual SIRT6/Classical HDAC Inhibitor with Integrated Antiproliferative, Antimigratory, and Pharmacokinetic Advantages Against Pancreatic Cancer

HTML

Year: 2026
Type: article
Source: Journal of Medicinal Chemistry
DOI: 10.1021/acs.jmedchem.6c02028
Authors: Shiying Zhu, En Liang, Bicong Cong, Qiao Li, Yunxia Cui, Lirong Zhang, Leisheng Xu, Yan Zheng, Mingzhu Zhao, Kui Cheng, Jian Zhang
Institutions: Southern Medical University, Shanghai Jiao Tong University
Language: English

Topic: Histone Deacetylase Inhibitors Research
Subfield: Molecular Biology
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: pancreatic cancer, SIRT6, histone deacetylase inhibitors, dual inhibitors, epithelial-mesenchymal transition, cell migration, antiproliferative activity, liver metastasis, metabolic stability, pharmacokinetics, E-cadherin, ZEB1, vimentin, small-molecule drug design
SDG: Good health and well-being

Open Access status: closed

Funders: Innovative Research Team of High-level Local University in Shanghai, National Natural Science Foundation of China, National Key Research and Development Program of China
Awards: G2030198899, G2174352892, G2824183592
OpenAlex ID: W7225879061
FWCI:
Cites: 45
Cited by:
Related to: 10
Parts: 5
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms